Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic · Tablet · Updated Nov 11, 2026

Lamivudine 300 mg tablet price what pharmacies pay, and what you should

Pharmacies pay$42.64for 30 tablets · $1.42 per tablet
Fair cash price$59.54cost + 15% + $10.50 fee
+1.4% in 4 weeks+11.7% in a yearLast change Oct 21, 2026: pharmacies' invoice prices changed (survey)

Is my price fair?

Check the price you were quoted

Type what the pharmacy asked for lamivudine 300 mg tablet and see the markup over what they pay.

How many?
$
Pharmacies payNADAC this week$42.64
Online cost-pluscost + 15% + fees$59.04
Fair cash pricecost + 15% + $10.50 fee$59.54
Your quotetype it above-
Pharmacies pay about $42.64 for 30 tablets. A fair cash price is around $59.54. Type your quote to see your markup.

A benchmark from public data, not a price offer or medical advice. Prices vary by pharmacy, insurance and discount programs.

Lamivudine 300 mg price history

What pharmacies pay for 30 tablets, weekly
$37.57$39.47$41.36$43.26DecFebAprJunAugOct
What pharmacies paid for 30 tablets of lamivudine 300 mg tablet over 52 weeks: from $38.19 on Nov 12, 2025 to $42.64 on Nov 11, 2026.
Now
$42.64
52-week low
$38.75
52-week high
$42.64
A year ago
$38.19

Why the price changed

EffectiveBeforeAfterChangeReason
Oct 21, 2026$1.40$1.42+1.4%pharmacies' invoice prices changed (survey)
Sep 23, 2026$1.37$1.40+2.1%pharmacies' invoice prices changed (survey)
Aug 19, 2026$1.36$1.37+0.6%pharmacies' invoice prices changed (survey)
Jul 22, 2026$1.35$1.36+1.2%pharmacies' invoice prices changed (survey)
Jun 17, 2026$1.31$1.35+3.1%pharmacies' invoice prices changed (survey)
May 20, 2026$1.29$1.31+1.3%pharmacies' invoice prices changed (survey)
Apr 22, 2026$1.34$1.29-3.3%pharmacies' invoice prices changed (survey)
Mar 18, 2026$1.34$1.34-0.6%pharmacies' invoice prices changed (survey)

Prices per tablet. Reasons are the ones the national survey gives: a survey rate change comes from pharmacies' own invoices; a published price change follows the maker's list price.

What did you pay for lamivudine 300 mg tablet? Share it.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Supply status: shortages & recalls

In shortage2 products are short or being discontinued
No ongoing recalls4 recalls on record, latest Sep 18, 2019

Shortages

  • Epivir, Tablet, 300 mg (NDC 49702-204-13)ViiV Healthcare Company · Being discontinued Oct 19, 2026 · Updated Oct 19, 2026The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug
  • Epivir, Tablet, 150 mg (NDC 49702-203-18)ViiV Healthcare Company · Being discontinued Oct 19, 2026 · Updated Oct 19, 2026The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

Every manufacturer and package code

3 companies sell lamivudine 300 mg tablet under 3 package codes (NDCs). Pharmacies pay the same per tablet whichever maker they buy from - the national average is set for the generic as a group.

MakerPack sizesPackage codesPer unit
Apotex Corp.30 tablets60505-3252-3 $1.42
Macleods Pharmaceuticals Limited30 tablets33342-002-07 $1.42
Strides Pharma Science Limited30 tablets64380-711-04 $1.42
All 3 package codes

A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.

Questions to ask your pharmacist

  1. "What is your cash price, without insurance?" For low-cost generics it can be less than a copay.
  2. "Is a 90-day supply cheaper per tablet?" Dispensing fees are charged per fill, so fewer fills often cost less.
  3. "Would 150 mg tablet work for me instead?" Pharmacies pay $0.4801 per tablet for it, against $1.42 for this one. Only your prescriber can say whether a different strength or form suits you.
  4. "Do you match other pharmacies or accept discount cards?" Many do, if you ask.

These are questions, not advice. Never change how you take a medicine without talking to your prescriber or pharmacist.

Other lamivudine strengths and forms

Strength and formPer unitPharmacies pay4 weeks52 weeks
10 mg/mL oral solution$0.2176$52.23 / 240 mLNo change-6.1%
100 mg tablet$9.08$272.28 / 30 tablets-4.2%+4.6%
150 mg tablet$0.4801$14.40 / 30 tablets-1.8%+16.3%

Official label & what changed

Last changedJuly 31, 2026
Version6 of 6
EffectiveJul 29, 2026
Read the label

These highlights do not include all the information needed to use LAMIVUDINE TABLETS (HBV) safely and effectively. See full prescribing information for LAMIVUDINE TABLETS (HBV). LAMIVUDINE tablets (HBV), for oral use Initial U.S. Approval: 1995

This drug has a boxed warning

WARNING: EXACERBATIONS OF HEPATITIS B and RISK OF HIV-1 RESISTANCE IF LAMIVUDINE TABLETS (HBV) IS USED IN PATIENTS WITH UNRECOGNIZED OR UNTREATED HIV-1 INFECTION

Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy (including lamivudine tablets (HBV). Hepatic function should be monitored closely with both clinical and laboratory follow-up for at least several months in patients who discontinue anti-hepatitis B therapy. If appropriate, initiation of anti-hepatitis B therapy may be warranted

[see

Warnings and Precautions (5.1)].

Lamivudine tablets (HBV) are not approved for the treatment of human immunodeficiency virus type 1 (HIV-1) infection because the lamivudine dosage in lamivudine tablets (HBV) is subtherapeutic and monotherapy is inappropriate for the treatment of HIV-1 infection. HIV-1 resistance may emerge in chronic hepatitis B-infected patients with unrecognized or untreated HIV-1 infection. HIV counseling and testing should be offered to all patients before beginning treatment with lamivudine tablets (HBV) and periodically during treatment

[see

Warnings and Precautions (5.2)].

WARNING: EXACERBATIONS OF HEPATITIS B and RISK OF HIV-1 RESISTANCE IF LAMIVUDINE TABLETS (HBV) IS USED IN PATIENTS WITH UNRECOGNIZED OR UNTREATED HIV-1 INFECTION

See full prescribing information for complete boxed warning

• Severe acute exacerbations of hepatitis B have been reported in patients who have discontinued anti-hepatitis B therapy (including lamivudine tablets (HBV). Monitor hepatic function closely in these patients and, if appropriate, initiate anti-hepatitis B treatment. (

5.1)

• Lamivudine tablets (HBV) contain a lower dose of the same active ingredient (lamivudine) as lamivudine tablets and oral solution used to treat human immunodeficiency virus type 1 (HIV-1) infection. HIV-1 resistance may emerge in chronic hepatitis B patients with unrecognized or untreated HIV-1 infection because the lamivudine dosage in lamivudine tablets (HBV) is subtherapeutic and monotherapy is inappropriate for the treatment of HIV-1 infection. HIV counseling and testing should be offered to all patients before beginning treatment with lamivudine tablets (HBV) and periodically during treatment. (

5.2)

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Questions about lamivudine 300 mg tablet

How much does lamivudine 300 mg tablet cost without insurance?

Pharmacies pay about $42.64 for 30 tablets ($1.42 per tablet) as of November 11, 2026. A fair cash price is about $59.54: that cost plus a 15% margin and a $10.50 dispensing fee. Online cost-plus pharmacies charge around $59.04 including shipping.

Is my price for lamivudine 300 mg tablet fair?

Compare it with the fair cash price of $59.54 for 30 tablets. Up to about $74.42 is fair; above $119.08 is high, and worth asking the pharmacy for its cash price or trying another pharmacy. Check your quote.

Is lamivudine 300 mg tablet getting more expensive?

Over the last four weeks the price pharmacies pay rose 1.4%. Over a year it rose 11.7%. See the 52-week chart.

Who makes lamivudine 300 mg tablet?

3 companies: Apotex Corp., Macleods Pharmaceuticals Limited, Strides Pharma Science Limited. See every package code.

Is lamivudine in shortage?

Yes - 2 products are listed as short or being discontinued. Details.

Has lamivudine been recalled?

4 recalls on record. Recalls name specific lots - check yours.

What does "pharmacies pay" mean?

It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.

Talk about lamivudine 300 mg tablet

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.